PROSTATE CANCER: EXPLORING ALL FORMS OF TREATMENTS FOR PROSTATE CANCER. Questo articolo non è disponibile.
Lingua: inglese
Editore: Independently published, 2024
- Brossura
- Nuovo

Da: Ria Christie Collections, Uxbridge, Regno UnitoRia Christie Collections
Venditore con 5 stelle
Venditore AbeBooks dal 25 marzo 2015
Non disponibile
Brossura
Condizione: Nuovo
EUR 17,10
Descrizione dell’articolo da parte del venditore
In English.
Codice articolo ria9798878958295_new
- Titolo
- PROSTATE CANCER: EXPLORING ALL FORMS OF TREATMENTS FOR PROSTATE CANCER
- Autore
- WALLER, DR. J.
- Editore
- Independently published
- Anno di pubblicazione
- 2024
- Condizione
- New
- Rilegatura
- Brossura
- Lingua
- inglese
- ISBN 13
- 9798878958295
- Peso dell'articolo
- 231 grammi
One type of cancer that arises in the prostate is prostate cancer. The prostate is a tiny gland that resembles a walnut that is situated in front of the rectum and beneath the bladder in males. During ejaculation, the prostate gland secretes a fluid that feeds and moves sperm.
One of the most prevalent diseases in males is prostate cancer, yet many of these instances grow slowly and may not pose a serious threat. On the other hand, malignant prostate cancers have the potential to spread to other body areas.
Age (risk rises with age), family history, race (African American males are more likely to get prostate cancer), and some genetic variables are risk factors for prostate cancer. Although the precise etiology of prostate cancer is unknown, hormonal fluctuations, prostatic inflammation, and genetics may all play a role in its development.
Prostate-specific antigen (PSA) blood tests and digital rectal exams (DREs) are common screening procedures used to identify early-stage prostate cancer, which may not exhibit any symptoms at all. Prostate cancer in its advanced stages can cause symptoms such as blood in the urine, erectile dysfunction, trouble urinating, and bone discomfort.
Prostate cancer treatment options are contingent upon a number of criteria, such as the patient's general health, the tumor's aggressiveness, and the cancer's stage. Treatment options include hormone therapy, radiation therapy, chemotherapy, active surveillance, surgery, and/or a combination of these.
One of the most prevalent diseases in males is prostate cancer, yet many of these instances grow slowly and may not pose a serious threat. On the other hand, malignant prostate cancers have the potential to spread to other body areas.
Age (risk rises with age), family history, race (African American males are more likely to get prostate cancer), and some genetic variables are risk factors for prostate cancer. Although the precise etiology of prostate cancer is unknown, hormonal fluctuations, prostatic inflammation, and genetics may all play a role in its development.
Prostate-specific antigen (PSA) blood tests and digital rectal exams (DREs) are common screening procedures used to identify early-stage prostate cancer, which may not exhibit any symptoms at all. Prostate cancer in its advanced stages can cause symptoms such as blood in the urine, erectile dysfunction, trouble urinating, and bone discomfort.
Prostate cancer treatment options are contingent upon a number of criteria, such as the patient's general health, the tumor's aggressiveness, and the cancer's stage. Treatment options include hormone therapy, radiation therapy, chemotherapy, active surveillance, surgery, and/or a combination of these.
"Riassunto" può appartenere a un’altra edizione di questo titolo.